Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Ringworm Treatment Market

Ringworm Treatment Market Size

  • Report ID: GMI6339
  • Published Date: Jul 2023
  • Report Format: PDF

Ringworm Treatment Market Size

Ringworm Treatment Market size was valued at USD 13.9 billion in 2022 and is expected to reach USD 21.3 billion by 2032, registering a CAGR of 4.1% during the forecast period. High prevalence of ringworm infections has significantly contributed to the rising demand for effective treatment options.

 

The availability of over-the-counter drugs for fungal infections coupled with rising awareness pertaining to ringworm infections & its symptoms has been instrumental in stimulating market growth. Also, public education campaigns and healthcare initiatives have sensitized individuals to recognize the early signs of ringworm, prompting them to seek timely treatment. This heightened awareness has not only improved patient outcomes but has also contributed to the overall of market expansion. Furthermore, advancements in medical research and technology have led to the development of innovative and more efficient antifungal drugs, thereby boosting the overall market size.

 

Ringworm is a fungal infection that develops on the skin's upper layer. It can occur or produce in any part of the body but majorly, it is developed on the legs and arms. Treatment for ringworm typically involves antifungal medications, that can be applied topically to the affected area or taken orally for more severe or widespread infections.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ringworm treatment industry was worth USD 13.9 billion in 2022 and is expected to reach USD 21.3 billion by 2032 driven by the rising demand for effective treatment options due to the high prevalence of ringworm infections.

The antifungals segment held 77.8% of the ringworm treatment market share in 2022 and is expected to expand at notable CAGR from 2023-2032 attributed to the continuous development of advanced and innovative formulations that cater to diverse patient needs.

North America ringworm treatment industry generated USD 6 billion in revenue in 2022 and is anticipated to witness 4.3% CAGR from 2023 – 2032 owing to the presence of robust healthcare infrastructure and advanced medical facilities in the region.

Some of the top firms operating in the ringworm treatment industry are Perrigo Company plc, Novartis AG, GlaxoSmithKline Plc, Teva Pharmaceutical Industries Ltd., GLENMARK PHARMACEUTICALS LTD., Pfizer Inc., Sanofi S.A., Merck & Co., Inc., Bayer AG, Gilead Sciences, Inc., and Eli Lilly and Company,

Ringworm Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 321
  • Countries covered: 18
  • Pages: 250
 Download Free Sample